Anika Therapeutics, Inc. (ANIK) Tops Q2 EPS by 3c, Revenue Light
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.42 +1.34%
Revenue Growth %: +3.5%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +3.5%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the quarter came in at $26.3 million versus the consensus estimate of $28.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Hyperscale Data launches $300M at-the-market stock offering
- Stifel downgrades Intuit to Hold on growth concerns, cuts target price
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
